Unitary Patent System – Updates
Liam Lawlor summaries the legal status of the European Unitary Patent System as it stands today.
News
JUNE UPDATE: Coronavirus pandemic advice from patent offices
UKIPO and EPO provide updates on extensions of time due to the coronavirus outbreak.
Repurposing, Repositioning and Rescue of Drugs and Pharmaceuticals
Following on from our News Article of 6 April 2020 “Personalised Medicine Patents at the EPO”, regarding a case law summary of the patent protection available for existing pharmaceuticals in terms of dosing regimens and specific patient groups, we now look to explore repurposing, repositioning and rescue (DRPx) of existing drugs and pharmaceuticals.
Stop Press: Decison today on Claims to Plants Produced by Essentially Biological Processes
The Enlarged Board of Appeal of the European Patent Office issued opinion G 3/19 (Pepper) today 14 May 2020 and concluded that plants and animals exclusively obtained by essentially biological processes are not patentable.
MAY UPDATE: Coronavirus pandemic advice from patent offices
The UK IPO and EPO remain “open for business” during the coronavirus outbreak with some deadlines extended.